![Michael Bailey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bailey
Vorsitzender bei
IMV INC.
Vermögen: 412 560 $ am 30.06.2026
Profil
Michael P.
Bailey is currently Chairman at IMV, Inc. since 2022, Director at AVEO Pharmaceuticals, Inc. since 2010, and Director at Verastem, Inc. starting in 2026.
Former roles include Member-Global Commercial Partnership Teams at Genentech, Inc., Senior Vice President-Commercial Operations at ImClone LLC from 1999 to 2008, and Chief Commercial Officer & Senior Vice President at Synta Pharmaceuticals Corp.
from 2008 to 2010.
Education includes undergraduate studies at St. Lawrence University and an MBA from Mendoza College of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VERASTEM, INC. 0,14 % | 21.05.2026 | 108.000 ( 0,14 % ) | 412 560 $ | 30.06.2026 |
Aktive Positionen von Michael Bailey
| Unternehmen | Position | Beginn |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 30.06.2026 |
| IMV INC. | Vorsitzender | 01.05.2022 |
| VERASTEM, INC. | Direktor/Vorstandsmitglied | 26.05.2026 |
Ehemalige bekannte Positionen von Michael Bailey
| Unternehmen | Position | Ende |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Corporate Officer/Principal | 07.09.2010 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01.08.2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Ausbildung von Michael Bailey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Mendoza College of Business
 Mendoza College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
